Search results
Results from the WOW.Com Content Network
Blue Cross Blue Shield payments to about 6 million people are set to go out more than two years after the health insurer reached a $2.67 billion settlement with subscribers.
Recent court ruling upholds the $2.67 billion agreement, pending additional appeals.
Hydroxycut is a brand of dietary supplements that is marketed as a weight loss aid. Hydroxycut was originally developed and manufactured by MuscleTech Research and Development; MuscleTech was sold to Iovate Health Sciences in 2003–2004 and declared bankruptcy in 2005; Iovate continues to use MuscleTech as a brand to market Hydroxycut.
Total settlement: $60 million. Deadline to file claim: May 18, 2023. Requirements: Must have been an unlimited data customer between Oct. 1, 2011 and June 30, 2015.
MuscleTech is a brand of dietary supplements, marketed by Iovate Health Sciences Inc., which includes Hydroxycut. It was owned by Canadian company Kerr Holdings which was acquired by the Xiwang Foodstuffs Company, a Chinese company, for $584 million in 2016.
The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2013, ordered by the size of the total settlement. The settlement amount includes both the civil (False Claims Act) settlement and criminal fine.
Though Blue Cross Blue Shield agreed to create a $2.67 billion settlement fund, only $1.9 billion remains available for payout after deducting attorney fees, administration expenses and other ...
In the first off-label promotion case ever litigated in a whistleblower suit under the False Claims Act, the settlement was announced after eight years of litigation in May 2004. Warner-Lambert agreed to pay $430 million to resolve all civil and criminal liability, with $24.64 million going to Franklin for his participation in the lawsuit. [2]